Fragile X testing after an autism diagnosis: who needs it and why

What Fragile X syndrome is

Fragile X syndrome is a genetic condition caused by a change in a single gene called FMR1, which sits on the X chromosome. Everyone’s FMR1 gene contains a short, repeated pattern of three DNA letters — C, G, G — repeated many times over. Most people have fewer than 45 repeats (National Fragile X Foundation, fragilex.org, 2026). When the repeat count grows past 200, the gene is silenced and stops producing its protein, FMRP, which brain cells need to build and maintain their connections (Hagerman et al., Nature Reviews Disease Primers, 2017).

Fragile X syndrome is the most common inherited cause of intellectual disability, and the leading known single-gene cause of autism (National Fragile X Foundation, fragilex.org, 2026; Hagerman et al., 2017). “Inherited” means it runs in families and traces to one identifiable gene — it does not mean every parent who carries the change will have an autistic child, or that every autistic child has it. Most do not.

Why it needs its own test

A chromosomal microarray looks for missing or duplicated chunks of chromosomes — a different kind of change from a repeat count inside one gene (chromosomal microarray, explained). Standard exome sequencing reads the protein-coding letters of DNA more or less one at a time, and it is not built to reliably count a long run of repeated letters like the CGG stretch in FMR1 — which is why the fragile X lab standards specify repeat-specific methods, including triplet repeat-primed and methylation-specific PCR alongside Southern blot, for sizing this gene (Monaghan et al., Genetics in Medicine, 2013). Our page on whole exome sequencing covers what that broader test does read. Both are strong tests for what they are designed to find. Neither one is designed to find this.

That is why a 2013 clinical genetics practice guideline recommends fragile X testing for every boy with unexplained autism as part of the first round of genetic evaluation, run alongside — not in place of — a chromosomal microarray, which the same guideline moved to a first-tier test (Schaefer & Mendelsohn, Genetics in Medicine, 2013). A more recent guideline on exome and genome sequencing recommends those broader tests as first- or second-tier testing for developmental delay or intellectual disability, but does not describe them as a substitute for fragile X testing (Manickam et al., Genetics in Medicine, 2021). If your child has already had a microarray or exome sequencing and Fragile X was never mentioned, it very likely has not been tested. Ask.

The full picture of what genetic testing can and cannot do, and how to prepare for it, is on the genetic testing, explained page.

How common Fragile X syndrome is among autistic children, and who gets tested

In a 2025 study of 441 people with autism spectrum disorder and/or intellectual disability in the country of Georgia, 1.9% of the autism-spectrum group tested positive for Fragile X syndrome — a little under 1 in 50 (Tabatadze et al., Frontiers in Pediatrics, 2025). How common it turns out to be depends heavily on who is in the study. The 2013 guideline’s own review of the literature found Fragile X in 6 of 1,215 children with autism — 0.5% — across three recent series, against 5.3% and 8% in two earlier ones (Schaefer & Mendelsohn, Genetics in Medicine, 2013). Somewhere between roughly 1 in 50 and 1 in 200 is the honest span, and it is high enough that the test is worth asking for either way. That is far higher than the rate in the general population: a systematic review and meta-analysis puts the full mutation at about 1 in 7,000 males and 1 in 11,000 females across the whole population, with the related, smaller premutation showing up in roughly 1 in 855 males and 1 in 291 females (Hunter et al., American Journal of Medical Genetics Part A, 2014). Similar population-level figures appear on the CDC’s Fragile X page (Centers for Disease Control and Prevention, 2026) and the National Fragile X Foundation’s overview (National Fragile X Foundation, fragilex.org, 2026).

The test itself is the same for boys and girls — the same blood or saliva sample, the same lab method. Who gets offered it is not quite the same. The 2013 guideline recommends that every boy with unexplained autism be tested for Fragile X syndrome, and that testing be seriously considered for a girl when something prompts it: features that fit Fragile X, a family history of X-linked developmental conditions, or early ovarian decline, tremors or balance problems in close relatives (Schaefer & Mendelsohn, Genetics in Medicine, 2013). Fragile X syndrome shows up more often, and often more visibly, in boys, because boys have only one X chromosome; a girl’s second X chromosome often — not always — softens the picture (National Fragile X Foundation, fragilex.org, 2026). If your daughter is autistic and any of those prompts fit your family, say so out loud when you ask. That is what moves the test from optional to indicated.

What the test actually is

Fragile X testing uses a blood sample in most labs, and some labs also accept saliva or a cheek swab (National Fragile X Foundation, fragilex.org, 2026). A lab first runs PCR (polymerase chain reaction) to count the CGG repeats in the FMR1 gene. If that count comes back high, a second method, Southern blot analysis, confirms the result and checks whether the gene has actually been silenced (Monaghan et al., Genetics in Medicine, 2013).

The result sorts into a few ranges:

• Under 45 repeats — typical range.
• 45 to 54 repeats — the intermediate range, sometimes called the “gray zone.” Your lab report will use the word intermediate. It is usually not linked to Fragile X syndrome or its related conditions.
• 55 to 200 repeats — a premutation. This does not cause Fragile X syndrome by itself, but it can expand further when passed to a child, and it comes with its own considerations for the adult who carries it.
• Over 200 repeats — a full mutation, which causes Fragile X syndrome (National Fragile X Foundation, fragilex.org, 2026; Hagerman et al., 2017).

Ask your lab or your genetics team for the exact number, not just which category it falls into — write it down, because you will be asked for it again.

What a result means for your child, and for your family

A full-mutation result explains something real about your child’s development, and it opens a specific, named path: fragile-X-specific clinics, condition-specific research, and a community of other families who have already been where you are. It does not set a ceiling on what your child will do, and it does not change who your child already is.

A premutation result is different, and it deserves its own conversation. Carrying a premutation does not cause Fragile X syndrome, but it can matter in two ways. First, it can grow when it is passed down, and which parent carries it changes what happens. A woman who carries a premutation has roughly a 50% chance of passing the change to each of her children, and the repeat count can expand into a full mutation on the way. A man who carries a premutation passes it to all of his daughters and none of his sons — and a premutation passed on by a father is very unlikely to expand into a full mutation (National Fragile X Foundation, fragilex.org, 2026). Second, adults who carry a premutation have a chance of developing one of two separate, named conditions later in life: fragile X-associated tremor/ataxia syndrome (FXTAS), a movement disorder, and fragile X-associated primary ovarian insufficiency (FXPOI), an early decline in ovarian function in premutation-carrying women (Monaghan et al., Genetics in Medicine, 2013).

This is exactly the kind of result a genetic counselor exists for. A genetic counselor can walk through what a specific number means for your child, for you if you turn out to carry a premutation, and for siblings or future children — at whatever pace your family wants that conversation to happen. Ask your genetics clinic for a referral if one has not already been offered.

What changes with a diagnosis

A confirmed Fragile X diagnosis can open several concrete things:

• A defined screening plan. Fragile X syndrome comes with a known pattern of related health considerations, sometimes including seizures, so a genetics team can lay out what to watch for and how often — instead of ordering one test at a time as new questions come up.
• Condition-specific supports and research. Because Fragile X syndrome is well studied, families can connect with fragile-X-specific clinics, registries, and research studies through organizations such as the National Fragile X Foundation (fragilex.org, 2026), alongside whatever general autism supports your family already uses.
• A documented explanation. A named genetic cause is something concrete to hand to a school team, a new clinician, or an insurer — evidence, not just a description of behavior. What a documented result can and cannot do for your family is covered in full on the understanding your results page.

Questions to ask genetics

1. Has Fragile X testing actually been done, or only a microarray or exome/genome test?
2. What is my child’s specific CGG repeat count, and which range does it fall into?
3. If this is a premutation, what does that mean for me and for other family members?
4. Is there a family-specific chance of Fragile X syndrome in future children, and how is that figured?
5. What screening schedule do you recommend now that we have this result?
6. What condition-specific resources or research studies would you recommend for our family?

Write the answers in your notebook. Every future clinician will ask the same things.

Questions parents ask after reading this

1. My child already had a chromosomal microarray or exome sequencing — do I still need to ask about Fragile X? Yes. Ask specifically, since neither test reliably catches the CGG repeat expansion that causes it.
2. My child’s Fragile X test came back negative — what should we test next? Ask your geneticist whether a chromosomal microarray or exome sequencing has been done, since a negative Fragile X result only rules out this one specific cause.
3. If my child has a premutation, does that mean I have one too? Not necessarily — a premutation can come from either parent, or, rarely, arise for the first time in your child. A genetic counselor can trace where it came from through targeted family testing.
4. Will a Fragile X diagnosis change my child’s school services? It can add medical screening and condition-specific resources; it rarely changes classroom strategy on its own, though you can bring the result to an IEP or 504 conversation if you think it is relevant.

If you only do three things

1. Ask your child’s clinician directly: “Has Fragile X testing been ordered — not just a microarray or exome test?” If the answer is unclear, ask for it in writing.
2. If a result comes back positive, whether premutation or full mutation, ask for a referral to a genetic counselor before you do anything else with the news.
3. Write down your child’s specific repeat-count range so you have it for every future clinician — genetics visits go faster with the exact number in hand.

You are allowed to ask the same question twice until you get a clear answer. That is not a bother; that is the job.